{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T12:43:12Z","timestamp":1754397792264},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1097\/ppo.0b013e31826aeeb2","type":"journal-article","created":{"date-parts":[[2012,9,21]],"date-time":"2012-09-21T21:40:28Z","timestamp":1348263628000},"page":"445-449","source":"Crossref","is-referenced-by-count":6,"title":["Should Patients With Aggressive Peripheral T-Cell Lymphoma All Be Treated the Same?"],"prefix":"10.1097","volume":"18","author":[{"given":"Alison J.","family":"Moskowitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew A.","family":"Lunning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven M.","family":"Horwitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-11-20210203","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killerT-cell lymphoma study: pathology findings and clinical outcomes.","volume":"26","author":"Vose","year":"2008","journal-title":"J Clin Oncol"},{"key":"R2-11-20210203","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/annonc\/mdh392","article-title":". Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification.","volume":"15","author":"Savage","year":"2004","journal-title":"Ann Oncol"},{"key":"R3-11-20210203","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1182\/blood-2010-02-270785","article-title":". Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group.","volume":"116","author":"Schmitz","year":"2010","journal-title":"Blood"},{"key":"R4-11-20210203","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1182\/blood-2007-02-074641","article-title":". Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial.","volume":"110","author":"Gallamini","year":"2007","journal-title":"Blood"},{"key":"R6-11-20210203","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1200\/JCO.2008.17.4870","article-title":". Autologous stem-cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter study.","volume":"27","author":"Reimer","year":"2009","journal-title":"J Clin Oncol"},{"key":"R7-11-20210203","first-page":"331","article-title":"F, Relander T, Lauritzsen GF, et al.. High-dose chemotherapy and autologuos stem cell transplantation in previously untreated peripheral T-cell lymphomafinal analysis of a large prospective multicenter study (NLG-T-01).","volume":"118","year":"2011","journal-title":"ASH Annu Meet Abstr"},{"key":"R8-11-20210203","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1182\/blood-2003-09-3080","article-title":". Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study.","volume":"103","author":"Gallamini","year":"2004","journal-title":"Blood"},{"key":"R9-11-20210203","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1182\/blood-2010-09-310342","article-title":". Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project.","volume":"117","author":"Weisenburger","year":"2011","journal-title":"Blood"},{"key":"R10-11-20210203","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1200\/JCO.2005.03.6327","article-title":". Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score.","volume":"24","author":"Went","year":"2006","journal-title":"J Clin Oncol"},{"key":"R11-11-20210203","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3109\/10428194.2011.645818","article-title":"Long-term survival in patients with peripheral T-cell non-Hodgkin lymphomas after allogeneic hematopoietic stem cell transplant.","volume":"53","author":"Goldberg","year":"2012","journal-title":"Leuk Lymphoma"},{"key":"R12-11-20210203","first-page":"1244","article-title":"Cheson, et al..","volume":"17","year":"1999","journal-title":"J Clin Oncol"},{"key":"R13-11-20210203","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1600-0609.2007.00856.x","article-title":". Frontline autologous stem cell transplantation in high-risk peripheral T-cell lymphoma: a prospective study from The Gel-Tamo Study Group.","volume":"79","author":"Rodriguez","year":"2007","journal-title":"Eur J Haematol"},{"key":"R14-11-20210203","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2214\/AJR.09.3665","article-title":". Characterization of T-cell lymphomas by FDG PETCT.","volume":"195","author":"Feeney","year":"2010","journal-title":"Am J Roentgenol"},{"key":"R15-11-20210203","first-page":"1956","article-title":". Negative interim FDG-PET scan is predictive of superior outcome in T cell lymphoma.","volume":"114","author":"Casulo","year":"2009","journal-title":"ASH Annu Meet Abstr"},{"key":"R16-11-20210203","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1470-2045(08)70002-0","article-title":"Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20 B-cell lymphomas: a randomised controlled trial (RICOVER-60).","volume":"9","author":"Pfreundschuh","year":"2008","journal-title":"Lancet Oncol"},{"key":"R17-11-20210203","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/sj.leu.2404306","article-title":"Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation.","volume":"20","author":"Corradini","year":"2006","journal-title":"Leukemia"},{"key":"R18-11-20210203","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1093\/annonc\/mdn022","article-title":"Intensive chemotherapy (high-dose CHOPESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma.","volume":"19","author":"Mercadal","year":"2008","journal-title":"Ann Oncol"}],"container-title":["The Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PPO.0b013e31826aeeb2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T05:26:43Z","timestamp":1620970003000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00130404-201209000-00011"}},"subtitle":["No\u2026 Well Yes, \u2026But Maybe Not for Long"],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/ppo.0b013e31826aeeb2","relation":{},"ISSN":["1528-9117"],"issn-type":[{"value":"1528-9117","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}